(Total Views: 254)
Posted On: 11/12/2017 5:28:32 PM
Post# of 99438
$OWCP may be worth another look, guys. Currently a fairly stable PPS around $0.32 with a previous 52-week High of $3.23 (February 22nd). However, the company, it's research & development, and sales timeline are MUCH better NOW than back in February.
Check out this blog -- "Breaking Down the Updated #Investor Presentation"
http://ownthefloat.com/index.php/2017/11/12/o...sentation/
$OWCP, under the leadership of an experienced Biotech exec (Dr. Stanley Hirsch), has put out some nice timelines.
They are expected to cross-list on a Canadian exchange VERY SOON, at which point we feel many updates will come. Especially when some of them were touched on in the latest Investor Presentation.
Many are expecting sales to start in Europe soon with Canada to follow soon after. This will be dispensary type sales, of course, as they continue on with Studies and eventually try for FDA Approval.
All in my opinion, of course.
Check out this blog -- "Breaking Down the Updated #Investor Presentation"
http://ownthefloat.com/index.php/2017/11/12/o...sentation/
$OWCP, under the leadership of an experienced Biotech exec (Dr. Stanley Hirsch), has put out some nice timelines.
They are expected to cross-list on a Canadian exchange VERY SOON, at which point we feel many updates will come. Especially when some of them were touched on in the latest Investor Presentation.
Many are expecting sales to start in Europe soon with Canada to follow soon after. This will be dispensary type sales, of course, as they continue on with Studies and eventually try for FDA Approval.
All in my opinion, of course.
(1)
(0)
